SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VERISANTE TECHNOLOGY

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: croman2/8/2013 10:34:34 AM
  Read Replies (1) of 254
 
And more news,,,,,,

Mr. Thomas Braun reports

VERISANTE TECHNOLOGY, INC. RETAINS HAMZA THINDAL CAPITAL CORP. FOR INVESTOR RELATIONS

Verisante Technology Inc. has retained Hamza Thindal Capital Corp. for investor relations to help broaden investor awareness via the firm's established network of investors in North America, Europe and the Gulf/Middle East and North Africa region.

"We are very pleased to start working with the team at Verisante as they enter an exciting phase of their commercialization strategy. As a medical doctor, I understand the real need for the revolutionary products in Verisante's pipeline," said Dr. Essam Hamza, MD, chief executive officer of Hamza Thindal. "Our unique approach, experience and successful track record of working with development-stage health care companies fits very well with Verisante as the company begins full commercialization," added Kam Thindal, president of Hamza Thindal.

"Hamza Thindal's experience and expertise in the health care market is impressive," said Thomas Braun, president and chief executive officer of Verisante. "We are looking forward to working with their team to increase awareness and strengthen shareholder communication."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext